[1] Jansz T T, Go M H Y, Hartkamp N S, et al. Coronary artery calcification as a marker for coronary artery stenosis: comparing kidney failure to the general population[J]. Kidney Med, 2021, 3(3): 386-394.e1.
[2] Nishizawa Y, Miyata S, Tosaka M, et al. Serum oxalate concentration is associated with coronary artery calcification and cardiovascular events in Japanese dialysis patients. Sci Rep, 2023,13(1):185-188.
[3] Xiong L, Chen Q Q, Cheng Y, et al. The relationship between coronary artery calcification and bone metabolic markers in maintenance hemodialysis patients[J]. BMC Nephrol, 2023, 24(1): 238.
[4] Xiong Y Q, Yu Y, Jiang H, et al. Visceral fat area is a better predictor than coronary artery calcification score for cardiovascular outcomes and All-Cause death in patients on hemodialysis[J]. J Ren Nutr, 2021, 31(3): 306-312.
[5] 王小琪, 袁丹, 邵枫, 等. 基于生物电阻抗方法分析血液透析患者内脏脂肪面积与腹主动脉钙化的相关性研究[J]. 首都医科大学学报, 2024, 45(1): 127-132.
[6] Chang M L, Yang Z, Yang S S. Roles of adipokines in digestive diseases: markers of inflammation, metabolic alteration and disease progression[J]. Int J Mol Sci, 2020, 21(21): 8308.
[7] Hug C, Lodish H F. Medicine. Visfatin: a new adipokine. Science, 2005,307(5708):366-367.
[8] Tang X L, Chen M Y, Zhang W R. Association between elevated visfatin and carotid atherosclerosis in patients with chronic kidney disease[J]. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2013, 38(6): 553-559.
[9] Daugirdas J T. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error[J]. J Am Soc Nephrol, 1993, 4(5): 1205-1213.
[10] Berman D S, Arnson Y, Rozanski A. Coronary artery calcium scanning: the agatston score and beyond[J]. JACC Cardiovasc Imaging, 2016, 9(12): 1417-1419.
[11] An S, Fan R R, Zhao B L, et al. Evaluating coronary artery calcification with low-dose chest CT reconstructed by different kernels[J]. Clin Imaging, 2022, 83: 166-171.
[12] King S A, Jenkins J D, Livesay J, et al. Coronary artery calcification and risk of cardiac complication in geriatric trauma population[J]. J Am Coll Surg, 2024, 238(4): 762-767.
[13] Uz O, Kardeşog∨lu E, Yig∨iner O, et al. The relationship between coronary calcification and the metabolic markers of osteopontin, fetuin-A, and visfatin[J]. Turk Kardiyol Dern Ars, 2009, 37(6): 397-402.
[14] Semerena E, Nencioni A, Masternak K. Extracellular nicotinamide phosphoribosyl transferase: role in disease pathophysiology and as a biomarker[J]. Front Immunol, 2023, 14: 1268756.
[15] Akcabag E, Bayram Z, Kucukcetin I O, et al. Functional effects of visfatin in isolated rat mesenteric small resistance arteries[J]. Eur J Pharmacol, 2021, 908: 174333.
[16] Muruganandan S, Ionescu A M, Sinal C J. At the crossroads of the adipocyte and osteoclast differentiation programs: future therapeutic perspectives[J]. Int J Mol Sci, 2020, 21(7): 2277.
[17] Cui L W, Xu J S, Bai Y L, et al. Risk factors for coronary artery calcification in patients with end-stage renal disease[J]. Zhonghua Yi Xue Za Zhi, 2015, 95(38): 3133-3137.
[18] 陈燕文, 陈都, 甘春蕾, 等. 维持性血液透析患者血清BMP-2和BMP-4水平与血管钙化的关系[J]. 临床误诊误治, 2021, 34 (8): 91-95.
|